- Home
- TECH vs ACHC Comparison
TECH vs ACHC Comparison
Compare TECH & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- ACHC
- Stock Information
- Founded
- TECH 1976
- ACHC 2005
- Country
- TECH United States
- ACHC United States
- Employees
- TECH N/A
- ACHC N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- ACHC Medical Specialities
- Sector
- TECH Health Care
- ACHC Health Care
- Exchange
- TECH Nasdaq
- ACHC Nasdaq
- Market Cap
- TECH 7.9B
- ACHC 2.1B
- IPO Year
- TECH 1989
- ACHC N/A
- Fundamental
- Price
- TECH $47.86
- ACHC $25.72
- Analyst Decision
- TECH Buy
- ACHC Strong Buy
- Analyst Count
- TECH 10
- ACHC 10
- Target Price
- TECH $73.44
- ACHC $52.25
- AVG Volume (30 Days)
- TECH 2.3M
- ACHC 3.6M
- Earning Date
- TECH 05-07-2025
- ACHC 05-12-2025
- Dividend Yield
- TECH 0.67%
- ACHC N/A
- EPS Growth
- TECH N/A
- ACHC N/A
- EPS
- TECH 0.83
- ACHC 2.04
- Revenue
- TECH $1,208,770,000.00
- ACHC $3,156,417,000.00
- Revenue This Year
- TECH $8.19
- ACHC $7.90
- Revenue Next Year
- TECH $8.61
- ACHC $8.58
- P/E Ratio
- TECH $57.61
- ACHC $12.60
- Revenue Growth
- TECH 4.72
- ACHC 5.48
- 52 Week Low
- TECH $46.44
- ACHC $20.36
- 52 Week High
- TECH $85.57
- ACHC $82.41
- Technical
- Relative Strength Index (RSI)
- TECH 41.02
- ACHC 53.03
- Support Level
- TECH $46.77
- ACHC $23.83
- Resistance Level
- TECH $54.40
- ACHC $28.48
- Average True Range (ATR)
- TECH 2.12
- ACHC 1.29
- MACD
- TECH 0.45
- ACHC 0.71
- Stochastic Oscillator
- TECH 14.29
- ACHC 61.56
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.